Drugs / TG-C
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05276011 Comparator | Oct 2026 → Oct 2027 expected | osteoarthritis, hip | Kolon TissueGene, Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TG-C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05276011 ↗ |
| Modality | Cell therapy | “non-transduced human chondrocytes and irradiated transduced human GP2-293 cells” NCT05276011 ↗ |
| Route | Other | “intra-articular injection” NCT05276011 ↗ |